GlassScriptPhysician profile
Steven Wayne Nakano
NPI 1053793760
$7,381.47
in general payments reported to CMS, 2019-2025
16 companies · $274 in 2025
The $274 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,300 · 2020: $4,600 · 2021: $598 · 2022: $24.85 · 2023: $438 · 2024: $147 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $858.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $858.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $4,736.77 | 2019-2020 | |
| Abbvie INC. | $553.24 | 2019-2025 | |
| Acadia Pharmaceuticals INC | $438.90 | 2021-2024 | Nuplazid |
| Allergan, INC. | $269.00 | 2019-2021 | |
| Abbott Laboratories | $211.73 | 2020-2022 | |
| Amneal Pharmaceuticals LLC | $202.93 | 2019-2025 | Rytary |
| Adamas Pharmaceuticals, INC. | $189.91 | 2019-2021 | |
| Kyowa Kirin, INC. | $168.21 | 2019-2021 | |
| Boston Scientific Corporation | $149.30 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $131.46 | 2019 | |
| Lundbeck LLC | $107.97 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $106.66 | 2019-2020 | |
| Acorda Therapeutics, INC | $46.21 | 2019-2021 | |
| Mdd US Operations, LLC | $32.54 | 2021 | |
| Avanir Pharmaceuticals, INC. | $19.19 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $17.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Nakano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.